ADAR1 Capital Management reports $14,530 InMed Pharmaceuticals common shares purchase
Bitget2026/10/08 22:28ADAR1 Capital Management raised its indirect stake in InMed Pharmaceuticals to 945,924 common shares. Purchases totaled 10,903 shares at $1.3277, $1.33, $1.3283 per share. Daniel Schneeberger, manager, reported the holdings as part of a group filing. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. InMed Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001940272-26-000023), on October 08, 2026, and is solely responsible for the information contained therein.
- ADAR1 Capital Management raised its indirect stake in InMed Pharmaceuticals to 945,924 common shares.
- Purchases totaled 10,903 shares at $1.3277, $1.33, $1.3283 per share.
- Daniel Schneeberger, manager, reported the holdings as part of a group filing.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canadian used car dealer UC Automotive (UCAU.RC.US) files for IPO in the US: aims to raise 29 million USD and list on Nasdaq
Canadian used car dealer UC Automotive has applied for a Nasdaq IPO, aiming to raise up to $29 million, with its main focus on the Greater Vancouver market. Kingswood is the sole underwriter.
Swiss Franc weakens as Fed hawkish outlook lifts USD/CHF
Crypto prices
More
